How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Robotic Surgery Assistance System Market
- By Surgical Application: Urology, Gynecology, General Surgery, Cardiothoracic Surgery, Orthopedic Surgery, Neurosurgery
- By Component Type: Robotic Arms, Imaging Systems, Control Systems, Endoscopic Instruments, Software Platforms
- By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
- By Surgery Approach: Laparoscopic Surgery, Minimally Invasive Surgery, Open Surgery
- By Technology: Haptic Feedback Systems, Artificial Intelligence Integration, 3D Visualization Systems, Teleoperated Robotic Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Urology leads By Surgical Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Robotic Surgery Assistance System Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Surgical Application 6
Component Type 5
End User 3
Surgery Approach 3
Technology 4
Companies profiled
Intuitive Surgical Inc.
Medtronic plc
Stryker Corporation
Smith & Nephew plc
TransEnterix
Inc. (Asensus Surgical)
Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)
Zimmer Biomet Holdings Inc.
Renishaw plc
CMR Surgical Ltd.
Hansen Medical
Inc. (acquired by Auris Health
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Intuitive Surgical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Smith & Nephew plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →TransEnterix
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Inc. (Asensus Surgical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Zimmer Biomet Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Renishaw plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →CMR Surgical Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Hansen Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Inc. (acquired by Auris Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →now part of Johnson & Johnson)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Titan Medical Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Medicaroid Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Verb Surgical Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,538M by 2033 · 9.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Urology44.0
- Gynecology16.5
- General Surgery16.2
- Cardiothoracic Surgery8.8
- Orthopedic Surgery8.5
- Neurosurgery6.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,495M → $3,388M · 10.8%
Europe$1,042M → $2,199M · 9.8%
Asia Pacific$951.3M → $2,136M · 10.6%
Latin America$588.9M → $1,331M · 10.7%
Middle East and Africa$453.0M → $994.5M · 10.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.702026
9.722027
9.732028
9.732029
9.762030
9.762031
9.772032
9.782033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Intuitive Surgical Inc.23.6
- Medtronic plc14.3
- Stryker Corporation8.2
- Smith & Nephew plc7.6
- TransEnterix10.5
- Inc. (Asensus Surgical)7.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Surgical Application29.5%
Component Type17.2%
End User11.9%
Surgery Approach27.1%
Technology14.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.7
- Europe21.9
- Asia Pacific21.3
- Latin America13.2
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | 84 | 89 | 92 | 73 | 87 | 95 | 87 |
| Medtronic plc | 75 | 81 | 89 | 72 | 92 | 73 | 80 |
| Stryker Corporation | 79 | 87 | 66 | 71 | 75 | 85 | 77 |
| Smith & Nephew plc | 69 | 73 | 80 | 59 | 67 | 58 | 68 |
| TransEnterix | 77 | 51 | 57 | 68 | 71 | 76 | 67 |
| Inc. (Asensus Surgical) | 59 | 64 | 51 | 65 | 66 | 71 | 63 |
| Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson) | 55 | 60 | 56 | 55 | 55 | 43 | 54 |
| Zimmer Biomet Holdings Inc. | 49 | 54 | 42 | 52 | 57 | 60 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Intuitive Surgical Inc.
- Medtronic plc
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Medtronic plc | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Stryker Corporation | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Smith & Nephew plc | ✓ | ✓ | ✓ | − | − | ◐ |
| TransEnterix | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Inc. (Asensus Surgical) | ◐ | ◐ | − | − | ◐ | ◐ |
| Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson) | ◐ | ◐ | − | ◐ | ◐ | − |
| Zimmer Biomet Holdings Inc. | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Intuitive Surgical Inc.87
2Medtronic plc80
3Stryker Corporation77
4Smith & Nephew plc68
5TransEnterix67
6Inc. (Asensus Surgical)63
7Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)54
8Zimmer Biomet Holdings Inc.52
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Intuitive Surgical Inc.Medtronic plc
Challenger3
Strong scale, closing on the leaders.
Stryker CorporationSmith & Nephew plcTransEnterix
Contender1
Focused players with pockets of strength.
Inc. (Asensus Surgical)
Niche2
Specialists in a single segment or region.
Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)Zimmer Biomet Holdings Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Surgical Application in North America, then scale across Robotic Surgery Assistance System Market — a $208M beachhead inside a $4.03B market.
Beachhead (SOM)$208Mobtainable near-term
Serviceable (SAM)$1.46Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Urology
Best fit — highest urgency & budget in Surgical Application.
Economic buyer77 fit
Gynecology
Strong fit — clear ROI and a fast path to value.
End user68 fit
General Surgery
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surgical Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Component Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Surgical Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Robotic Surgery Assistance System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation14%
Closed-won6%
$9.6KCAC
$57KLTV
5.9:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Robotic Surgery Assistance System Market is a durable-growth opportunity — $8.89B by 2033, compounding at 9.7%.
TAM · 2025$4.24Btoday
TAM · 2033$8.89Bforecast
CAGR9.7%2027–2033
Cumulative$56.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.89BTotal addressable market
SAM$3.35BServiceable available market
SOM$635MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.7% CAGR
Demand compounds through 2033, outpacing GDP across Surgical Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surgical Application moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.89BLarge & growingTAM by 2033 at 9.7% CAGR
$3.35BServiceable nowreachable with today’s model
$635MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.93BBear6.3% CAGR
$8.89BBase9.7% CAGR
$11.4BBull12.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Component Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Robotic Surgery Assistance System Market — a $1.92B market by 2033. Plan: grow share from 5.1% to 11.1%.
Market size · 2033$1.92Btotal addressable
Market CAGR3.7%2027–2033
Target share11.1%from 5.1% today
Revenue ambition$213Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.1% | 11.1% | Ahead |
| Revenue | $89M | $213M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 34.9% | 39.6% | Behind |
| Customer retention | 88.2% | 93.9% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Surgical Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Component Type capability
A defensible second engine — invest in Component Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surgical Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Component Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $24M capacity & capability investment
- Greenlight bolt-on M&A in Component Type
- Authorise North America expansion plan
- Fund R&D program for Surgical Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Robotic Surgery Assistance System Market conversation — a $3.71B market you can size, segment and defend in minutes.
Market size · 2033$3.71Btotal opportunity
Growth9.9%CAGR to 2033
Addressable buyers1,488+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surgical Application
Goal Grow share in Surgical Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 4 mopayback period
$99K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Intuitive Surgical Inc.Medtronic plcStryker CorporationSmith & Nephew plcTransEnterixInc. (Asensus Surgical)Verb Surgical Inc. (a collaboration between Verily and Johnson & Johnson)Zimmer Biomet Holdings Inc.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Robotic Surgery Assistance System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Robotic Surgery Assistance System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Robotics in Healthcare Market
Robotics in Healthcare Market is valued at USD 8.7 Billion in 2025 and is expected to reach USD…
$8.7B market · 2025 base year
View reportRobotics for Physical Therapy Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportRobotic Scope Holder Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportRobotics Assisted Telesurgery Market
Market size, share, segmentation and regional forecast.
$560M market · 2025 base year
View reportRobotic Radiosurgery System Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportRobotic Puncture System Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportRobotic Pharmacy Dispensing System Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportRobotic Pharmacy Automation System Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportRobotic Patient Positioning System Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportRobotic Patient Positioning Solutions Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportRobotic Orthosis for Upper Limb Rehabilitation Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportRobotic Nurse Assistant Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.